Visibility in the media.
Stay informed with the latest press releases, media coverage, and corporate milestones shaping the future of retinal imaging.
See more news.
Uncover a world of information.
Access the latest on the evolution of retinal AI in healthcare.
Featured FAQs.
Direct answers to the most critical questions regarding our technology’s financial, technical, and clinical implementation.
The EyeArt system is cleared for use in adults who have been diagnosed with diabetes but have not been previously diagnosed with retinopathy. It is intended for use in frontline healthcare settings by trained professionals.
The EyeArt system is cleared for the autonomous detection of diabetic retinopathy, age-related macular degeneration, and glaucomatous optic nerve damage in adults with diabetes. This gives clinicians the actionable data to prioritize referrals for high-risk patients.
We recognize that every health system has a unique technical ecosystem. Eyenuk provides comprehensive collaboration to integrate EyeArt results into your specific EHR environment using industry-standard protocols. Our team partners with your IT and clinical leadership to navigate the nuances of your workflow, ensuring results are properly documented in the patient’s permanent record and manual data entry is minimized.
See all of our FAQs.